Kim, Youngeun
Lewis, Mary Beth
Hwang, Jihyun
Wang, Zheyu
Gupta, Rohit
Liu, Yuxiong
Gupta, Tuhina
Barber, James P.
Singamaneni, Srikanth
Quinn, Fred
Prausnitz, Mark R.
Funding for this research was provided by:
National Institutes of Health (EB025499, EB025499, EB025499, EB025499, EB025499, EB025499, EB025499)
National Science Foundation (CBET-2224610, CBET-2224610, CBET-2224610, CBET-2224610)
Article History
Accepted: 2 January 2024
First Online: 30 January 2024
Declarations
:
: Mark R. Prausnitz is an inventor of patents, a paid advisor, and a founder/shareholder of companies developing microneedle-based products. The associated conflict of interest has been disclosed and is managed by Georgia Institute of Technology. Srikanth Singamaneni is one of the inventors on a pending patent related to plasmonic fluor technology, and the technology has been licensed by the Office of Technology Management at Washington University in St Louis to Auragent Bioscience LLC, which is developing plasmonic fluor products. S.S. is one of the co-founders and shareholders of Auragent Bioscience LLC. These potential conflicts of interest have been disclosed and are being managed by Washington University in St Louis.The other authors do not declare any conflicts of interest.